Method of treating HIV infections with anti-viral formulations

Details Method of treating HIV infections with anti-viral formulations Method of treating HIV infections with anti-viral formulations

1997-04-01

1998-01-13

Henley, III, Raymond

Drug, bio-affecting and body treating compositions

Solid synthetic organic polymer as designated organic active...

A61K 3174

Patent

active

057076154

ABSTRACT:
The preferred oligomers of the present invention are polyureas, polycarbonates, polyesters or polyamides having a number average molecular weight of <10,000. These oligomers are water-soluble, have a rigid backbone, have recurring units coupled by carbonyl linking moieties which have anionic groups, display predominantly linear geomentry such that regular spacing between anionic groups exists in an aqueous medium, and are pharmaceutically-acceptable. The oligomers are useful for the treatment and/or diagnosis of AIDS and ARC.

REFERENCES:
patent: 2833744 (1958-05-01), Neher
patent: 3528949 (1970-09-01), Rutledge
patent: 4604404 (1986-08-01), Munson et al.
patent: 4783446 (1988-11-01), Neushul
patent: 4824916 (1989-04-01), Kershner et al.
patent: 4895660 (1990-01-01), Kershner
patent: 4966894 (1990-10-01), Herr et al.
patent: 5424063 (1995-06-01), Cardin et al.
Vandenberg E.J. et al., Polymeric Materials Science and Engineering vol. 57, Fall Meeting, 1987, pp. 139-143.
R.M. Ottenbrite, ACS Symposium Series #186, pp. 205-220 (1982) "The Antitumor and Antiviral Effects of Polycarboxyl-ic Acid Polymers".
European Chem. News, p. 17 (Jul. 30, 1990).
Ahmed, et al., Antiviral Chemistry & Chemotherapy, (1995) 6(1), 34-42, "Potent Inhibition of Herpes Simplex Virus by MDL101028" a Novel Biphenyl Disulphonic Acid Co-polymer.
Antiviral Research, 18(1992), Sulfonic acid polymers as a new class of human immunodefic-ciency virus inhibitors, Prem Mohan, et al., pp. 139-150.
Komp et al, Chemical Abstracts vol. 110 Abstract No. 33727k (1989).
Cardin et al. "Stilbene Disulfonic Acids. CD4 Antagonists that Block human immunodeficiency Virus Type-1 Growth at Multiple Stages of the Viral like Cycle" J. Biol. Chem (1991), 266(20), 13355-63.
Hofferek et al., Chemical Abstracts vol. 114: 180333q (1990).
Taylor et al, "Potent Inhibition of Human Immunodeficiency Virus (HIV) by MDL 101028", a Novel Supphonic Acid Polymer.
Antiviral Research, 18 (1992), Sulfonic acid polymers as a new class of human immunodefi-ciency virus inhibitors, Prem Mohan, et al., pp. 138-150.

Affiliated with

Also associated with

Rating

Method of treating HIV infections with anti-viral formulations does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating HIV infections with anti-viral formulations, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating HIV infections with anti-viral formulations will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-324026